Latest Updates
-
Father's Day 2026: Sunday Lunch Recipes That Bring Families Back To The Table -
Biggest OTT Releases This Week (June 15-21): What's Streaming On Netflix, Prime Video, JioHotstar And More -
International Yoga Day 2026: 852 Million People Have Insomnia. Here's What Yoga Offers -
Rich Mughlai Style Kaju Curry Recipe: A Royal Delight -
Why You Could Be Dehydrated During Rainy Weather Without Knowing It -
Skanda Shashti June 2026: Significance, Tithi Timings, Puja Vidhi And The Story Behind Lord Murugan's Victory -
World Sickle Day 2026: Significance, Theme And What It Reveals About Healthcare Access Gaps -
Iced Tea Recipe: Your Refreshing Summer Drink -
Horoscope for Today June 19, 2026 - Small Steps Lead to Steady Progress -
Dalma Recipe: An Odisha Traditional Dish Delight
Biomarkers That Predict Prostate Cancer Identified
{image- www.boldsky.com} Scientists from University of Texas Southwestern have identified seven biomarkers that may help predict prostate cancer recurrence in patients after surgery.
Biomarkers are proteins circulating in a patient"s blood that are specific to a disease.
Currently used risk assessment methods can predict prostate cancer recurrence with about 70 percent accuracy.
Dr Shahrokh Shariat, now a resident in urology at UT Southwestern revealed that with these newly identified biomarkers he was able to predict recurrence and progression with 86 percent accuracy.
Using commonly available blood testing methods, Dr. Shariat and his team measured the levels of seven biomarkers in 423 patients who were subsequently surgically treated with a radical prostatectomy and bilateral lymphadenectomy.
"There are several unresolved issues in the clinical and surgical management of prostate cancer, one of them being the identification of men who have insignificant cancers and can be followed, and another being the identification of men most likely to have spread of disease and early or late recurrence," said Dr. Claus Roehrborn, chairman of urology at UT Southwestern.
Of the study participants, 75 had a recurrence of their cancer. All 75 had elevated levels of at least several of the seven biomarkers. Dr. Shariat's seven-biomarker model was able to accurately predict the risk for recurrence 86.6 percent of the time.
"We found that a combination of independent yet complementary markers may provide a more accurate prediction outcome compared to single markers," Shariat said.
"This could help physicians provide individualized care and targeted therapy for patients. It will also allow us to design clinical trials to target these individual biomarkers," he added.
The study is published in the June 15 issue of Clinical Cancer Research
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications